144 related articles for article (PubMed ID: 16827800)
61. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
62. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
Zhao S; Liu WP; Zhang WY; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
[TBL] [Abstract][Full Text] [Related]
63. ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.
Nghiem P; Park PK; Kim Ys YS; Desai BN; Schreiber SL
J Biol Chem; 2002 Feb; 277(6):4428-34. PubMed ID: 11711532
[TBL] [Abstract][Full Text] [Related]
64. UV-induced photolesions elicit ATR-kinase-dependent signaling in non-cycling cells through nucleotide excision repair-dependent and -independent pathways.
Vrouwe MG; Pines A; Overmeer RM; Hanada K; Mullenders LH
J Cell Sci; 2011 Feb; 124(Pt 3):435-46. PubMed ID: 21224401
[TBL] [Abstract][Full Text] [Related]
65. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
66. Preferential binding of ATR protein to UV-damaged DNA.
Unsal-Kaçmaz K; Makhov AM; Griffith JD; Sancar A
Proc Natl Acad Sci U S A; 2002 May; 99(10):6673-8. PubMed ID: 12011431
[TBL] [Abstract][Full Text] [Related]
67. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.
Vadnais C; Davoudi S; Afshin M; Harada R; Dudley R; Clermont PL; Drobetsky E; Nepveu A
Nucleic Acids Res; 2012 May; 40(10):4483-95. PubMed ID: 22319212
[TBL] [Abstract][Full Text] [Related]
68. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
69. The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks.
Kennedy DR; Beerman TA
Biochemistry; 2006 Mar; 45(11):3747-54. PubMed ID: 16533058
[TBL] [Abstract][Full Text] [Related]
70. Checkpoint kinase ATR promotes nucleotide excision repair of UV-induced DNA damage via physical interaction with xeroderma pigmentosum group A.
Shell SM; Li Z; Shkriabai N; Kvaratskhelia M; Brosey C; Serrano MA; Chazin WJ; Musich PR; Zou Y
J Biol Chem; 2009 Sep; 284(36):24213-22. PubMed ID: 19586908
[TBL] [Abstract][Full Text] [Related]
71. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
74. EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma.
Huang WT; Lin CW
Am J Pathol; 2014 Apr; 184(4):1185-97. PubMed ID: 24655378
[TBL] [Abstract][Full Text] [Related]
75. Roles of nibrin and AtM/ATR kinases on the G2 checkpoint under endogenous or radio-induced DNA damage.
Marcelain K; De La Torre C; González P; Pincheira J
Biol Res; 2005; 38(2-3):179-85. PubMed ID: 16238096
[TBL] [Abstract][Full Text] [Related]
76. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control.
Wright JA; Keegan KS; Herendeen DR; Bentley NJ; Carr AM; Hoekstra MF; Concannon P
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7445-50. PubMed ID: 9636169
[TBL] [Abstract][Full Text] [Related]
77. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
[TBL] [Abstract][Full Text] [Related]
78. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
[TBL] [Abstract][Full Text] [Related]
79. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM
J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771
[TBL] [Abstract][Full Text] [Related]
80. Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.
Ito T; Kawazu H; Murata T; Iwata S; Arakawa S; Sato Y; Kuzushima K; Goshima F; Kimura H
Cancer Med; 2014 Aug; 3(4):787-95. PubMed ID: 24799376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
